These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28203226)

  • 1. Microbial Anti-Inflammatory Molecule (MAM) from
    Breyner NM; Michon C; de Sousa CS; Vilas Boas PB; Chain F; Azevedo VA; Langella P; Chatel JM
    Front Microbiol; 2017; 8():114. PubMed ID: 28203226
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
    Quévrain E; Maubert MA; Michon C; Chain F; Marquant R; Tailhades J; Miquel S; Carlier L; Bermúdez-Humarán LG; Pigneur B; Lequin O; Kharrat P; Thomas G; Rainteau D; Aubry C; Breyner N; Afonso C; Lavielle S; Grill JP; Chassaing G; Chatel JM; Trugnan G; Xavier R; Langella P; Sokol H; Seksik P
    Gut; 2016 Mar; 65(3):415-425. PubMed ID: 26045134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.
    Martín R; Chain F; Miquel S; Lu J; Gratadoux JJ; Sokol H; Verdu EF; Bercik P; Bermúdez-Humarán LG; Langella P
    Inflamm Bowel Dis; 2014 Mar; 20(3):417-30. PubMed ID: 24418903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation.
    Huang XL; Zhang X; Fei XY; Chen ZG; Hao YP; Zhang S; Zhang MM; Yu YQ; Yu CG
    World J Gastroenterol; 2016 Jun; 22(22):5201-10. PubMed ID: 27298563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from
    Auger S; Kropp C; Borras-Nogues E; Chanput W; Andre-Leroux G; Gitton-Quent O; Benevides L; Breyner N; Azevedo V; Langella P; Chatel JM
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.
    Xu J; Liang R; Zhang W; Tian K; Li J; Chen X; Yu T; Chen Q
    J Diabetes; 2020 Mar; 12(3):224-236. PubMed ID: 31503404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of pancreatitis-associated protein by Lactococcus lactis displays protective effects in dinitro-benzenesulfonic-acid-induced colitis model and is able to modulate the composition of the microbiota.
    Breyner NM; Vilas Boas PB; Fernandes G; de Carvalho RD; Rochat T; Michel ML; Chain F; Sokol H; de Azevedo M; Myioshi A; Azevedo VA; Langella P; Bermúdez-Humarán LG; Chatel JM
    Environ Microbiol; 2019 Nov; 21(11):4020-4031. PubMed ID: 31325218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain-Specific Anti-Inflammatory Effects of Faecalibacterium prausnitzii Strain KBL1027 in Koreans.
    Seo B; Jeon K; Kim WK; Jang YJ; Cha KH; Ko G
    Probiotics Antimicrob Proteins; 2024 Feb; ():. PubMed ID: 38411865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of a novel probiotic strain, Lactococcus lactis ML2018, in colitis: in vivo and in vitro evidence.
    Liu M; Zhang X; Hao Y; Ding J; Shen J; Xue Z; Qi W; Li Z; Song Y; Zhang T; Wang N
    Food Funct; 2019 Feb; 10(2):1132-1145. PubMed ID: 30724927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
    Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
    Sokol H; Pigneur B; Watterlot L; Lakhdari O; Bermúdez-Humarán LG; Gratadoux JJ; Blugeon S; Bridonneau C; Furet JP; Corthier G; Grangette C; Vasquez N; Pochart P; Trugnan G; Thomas G; Blottière HM; Doré J; Marteau P; Seksik P; Langella P
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16731-6. PubMed ID: 18936492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis.
    Petito V; Graziani C; Lopetuso LR; Fossati M; Battaglia A; Arena V; Scannone D; Quaranta G; Quagliariello A; Del Chierico F; Putignani L; Masucci L; Sanguinetti M; Sgambato A; Gasbarrini A; Scaldaferri F
    World J Gastroenterol; 2019 Mar; 25(12):1465-1477. PubMed ID: 30948910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis.
    Rossi O; Khan MT; Schwarzer M; Hudcovic T; Srutkova D; Duncan SH; Stolte EH; Kozakova H; Flint HJ; Samsom JN; Harmsen HJ; Wells JM
    PLoS One; 2015; 10(4):e0123013. PubMed ID: 25910186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses.
    Rossi O; van Berkel LA; Chain F; Tanweer Khan M; Taverne N; Sokol H; Duncan SH; Flint HJ; Harmsen HJ; Langella P; Samsom JN; Wells JM
    Sci Rep; 2016 Jan; 6():18507. PubMed ID: 26725514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
    Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR
    J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactooligosaccharides protects against DSS-induced murine colitis through regulating intestinal flora and inhibiting NF-κB pathway.
    Chu H; Tao X; Sun Z; Hao W; Wei X
    Life Sci; 2020 Feb; 242():117220. PubMed ID: 31881230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Delivery of Mouse β-Defensin 14 (mBD14)-Producing
    Tian H; Li J; Chen X; Ren Z; Pan X; Huang W; Bhatia M; Pan LL; Sun J
    J Agric Food Chem; 2023 Apr; 71(13):5185-5194. PubMed ID: 36943701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of live, but not inactivated, Faecalibacterium prausnitzii has a preventive effect on dextran sodium sulfate‑induced colitis in mice.
    Kawade Y; Sakai M; Okamori M; Morita M; Mizushima K; Ueda T; Takagi T; Naito Y; Itoh Y; Shimada T
    Mol Med Rep; 2019 Jul; 20(1):25-32. PubMed ID: 31115531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1.
    Zhou L; Zhang M; Wang Y; Dorfman RG; Liu H; Yu T; Chen X; Tang D; Xu L; Yin Y; Pan Y; Zhou Q; Zhou Y; Yu C
    Inflamm Bowel Dis; 2018 Aug; 24(9):1926-1940. PubMed ID: 29796620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.
    Miquel S; Leclerc M; Martin R; Chain F; Lenoir M; Raguideau S; Hudault S; Bridonneau C; Northen T; Bowen B; Bermúdez-Humarán LG; Sokol H; Thomas M; Langella P
    mBio; 2015 Apr; 6(2):. PubMed ID: 25900655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.